These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36123712)

  • 1. Joint effect of visit-to-visit variability in LDL-cholesterol, HDL-cholesterol and HbA1c on cardiovascular and total mortality in patients with diabetes.
    He P; Gan X; Wu Q; Ye Z; Yang S; Zhang Y; Li H; Zhou C; Zhang Y; Liu M; Qin X
    Diabetol Metab Syndr; 2022 Sep; 14(1):132. PubMed ID: 36123712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Variability and Risk of Cardiovascular Diseases and All-Cause Mortality: A Systematic Review and Meta-Analysis of Cohort Studies.
    Li S; Hou L; Zhu S; Yi Q; Liu W; Zhao Y; Wu F; Li X; Pan A; Song P
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Liu X; Wu S; Song Q; Wang X
    Atherosclerosis; 2020 Nov; 312():110-116. PubMed ID: 32958454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Long-Term Visit-to-Visit Hemoglobin A1c and Cardiovascular Risk in Type 2 Diabetes: The ACCORD Trial.
    Huang D; Huang YQ; Zhang QY; Cui Y; Mu TY; Huang Y
    Front Cardiovasc Med; 2021; 8():777233. PubMed ID: 34901237
    [No Abstract]   [Full Text] [Related]  

  • 7. Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes.
    Yeh ST; Ooi SW; Chang YH; Li CY; Chen HF
    Medicine (Baltimore); 2022 Aug; 101(33):e29942. PubMed ID: 35984136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
    Guyton JR; Slee AE; Anderson T; Fleg JL; Goldberg RB; Kashyap ML; Marcovina SM; Nash SD; O'Brien KD; Weintraub WS; Xu P; Zhao XQ; Boden WE
    J Am Coll Cardiol; 2013 Oct; 62(17):1580-4. PubMed ID: 23916935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study.
    Boey E; Gay GM; Poh KK; Yeo TC; Tan HC; Lee CH
    Atherosclerosis; 2016 Jan; 244():86-92. PubMed ID: 26595903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Visit-to-Visit Lipid Variability and Incident Cancer: A Population-based Cohort Study.
    Chan JSK; Satti DI; Lee YHA; Bin Waleed K; Tang P; Mahalwar G; Minhas AMK; Roever L; Biondi-Zoccai G; Leung FP; Wong WT; Liu T; Zhou J; Tse G
    Curr Probl Cardiol; 2023 Jan; 48(1):101421. PubMed ID: 36167221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of blood lipid variability on mortality in patients with type 2 diabetes: a large single-center cohort study.
    Wang MC; Li CI; Liu CS; Lin CH; Yang SY; Li TC; Lin CC
    Cardiovasc Diabetol; 2021 Nov; 20(1):228. PubMed ID: 34823536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis.
    Hukportie DN; Li FR; Zhou R; Zheng JZ; Wu XX; Zou MC; Wu XB
    J Diabetes; 2022 Jun; 14(6):365-376. PubMed ID: 35668633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-trajectories of lipid indices with incident cardiovascular disease, heart failure, and all-cause mortality: 23 years follow-up of two US cohort studies.
    Koohi F; Khalili D; Mansournia MA; Hadaegh F; Soori H
    J Transl Med; 2021 Jul; 19(1):286. PubMed ID: 34217318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results.
    Kaysen GA; Ye X; Raimann JG; Wang Y; Topping A; Usvyat LA; Stuard S; Canaud B; van der Sande FM; Kooman JP; Kotanko P;
    J Lipid Res; 2018 Aug; 59(8):1519-1528. PubMed ID: 29895699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visit-to-Visit Variability of Lipids Measurements and the Risk of Stroke and Stroke Types: A Prospective Cohort Study.
    Wang A; Li H; Yuan J; Zuo Y; Zhang Y; Chen S; Wu S; Wang Y
    J Stroke; 2020 Jan; 22(1):119-129. PubMed ID: 32027797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort.
    Fu L; Tai S; Sun J; Zhang N; Zhou Y; Xing Z; Wang Y; Zhou S
    Diabetes Care; 2022 Sep; 45(9):2136-2143. PubMed ID: 35834242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study.
    Yu Y; Li M; Huang X; Zhou W; Wang T; Zhu L; Ding C; Tao Y; Bao H; Cheng X
    Lipids Health Dis; 2020 Nov; 19(1):238. PubMed ID: 33183311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes.
    Clark D; Nicholls SJ; St John J; Elshazly MB; Kapadia SR; Tuzcu EM; Nissen SE; Puri R
    Eur Heart J; 2018 Jul; 39(27):2551-2558. PubMed ID: 29688308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
    Albers JJ; Slee A; Fleg JL; O'Brien KD; Marcovina SM
    Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between visit-to-visit variability of HbA
    Yu ZB; Zhu Y; Li D; Wu MY; Tang ML; Wang JB; Chen K
    Diabetologia; 2020 Jan; 63(1):85-94. PubMed ID: 31485707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.